跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ENERZAIR BREEZHALER 114 MICROGRAMOS/46 MICROGRAMOS/136 MICROGRAMOS POLVO PARA INHALACION (CAPSULA DURA)
Approved
STANDARD
ENERZAIR BREEZHALER 114 MICROGRAMOS/46 MICROGRAMOS/136 MICROGRAMOS POLVO PARA INHALACION (CAPSULA DURA)
Novartis Europharm Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 9, 2020
Approval ID
17ca7c125124ab77
Company
Novartis Europharm Limited
Type
Standard
Approval Details
Approval Id
17ca7c125124ab77
Drug Cima Aemps Name
ENERZAIR BREEZHALER 114 MICROGRAMOS/46 MICROGRAMOS/136 MICROGRAMOS POLVO PARA INHALACION (CAPSULA DURA)
Register Number
1201438002
Holder Company Name
Novartis Europharm Limited
Marketing Company Name
Laboratorios Menarini S.A.
Holder Company Detail Path
/organization/novartis-europharm-limited
Authorization Date
2020-08-09
Dosage Form
POLVO PARA INHALACIÓN (CÁPSULA DURA)
Dose
114 microgramos/46 microgramos/136 microgramos
Route Of Administration
VÍA INHALATORIA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Novartis Europharm Limited
Company Detail Path
/organization/novartis-europharm-limited
Company Information
Pharmaceutical Company Name
NOVARTIS EUROPHARM LIMITED
Country Name
United Kingdom
City Name
camberley,country_gb
Address
200 Frimley Business Park
Active Ingredients
INDACATEROL ACETATO
0,173 mg
GLICOPIRRONIO BROMURO
0,06358 mg
MOMETASONA FUROATO
0,16 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 9, 2020
Approval ID
17ca7c125124ab77
Type
Standard
Back to CIMA-AEMPS Approvals
ENERZAIR BREEZHALER 114 MICROGRAMOS/46 MICROGRAMOS/136 MICROGRAMOS POLVO PARA INHALACION (CAPSULA DURA) - CIMA-AEMPS Drug Approval Details